---
category: news
title: "Lantern Pharma Reports Third Quarter 2022 Financial Results and Operational Highlights"
excerpt: "Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR Â® artificial intelligence (\"A.I.\") and machine learning (\"M.L.\") platform to transform the cost,"
publishedDateTime: 2022-11-07T21:18:00Z
originalUrl: "https://technews.tmcnet.com/news/2022/11/07/9707792.htm"
webUrl: "https://technews.tmcnet.com/news/2022/11/07/9707792.htm"
type: article

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "JP1IwwUWAxoK43E0pboN+Fza01z+SgYs6YfoFGUI04PgLjSqlZ9L5hRyu680akD4nm5CJEg/78oVB9MYw+k1dDgI4ASt9zESZ924Qv0FZKC69HFEmS+OfO0bw47YnpjMKvQXuxh7+7WFIHonSk5c3Tbm1zYRRNbO6O0/seMRR8racEmfqnVUT5AMeD/lT0S3ivyQ1fY1cdkA7tGR2rtF+IqaW6XWS+BMOCHg3y5kz+RPykUbKeUKL5C37Bc3UYaP37n5Bg2JXk7ulxi5ybERhJXBjAyvwTiVKDhLatSdKL/bHk3kgd3AJ+6Sx/yVUZiLJOi5NXp0GUwlCBe1VFiVg/SAfhPuZMYZvHo99Es+694=;jjVaym6CoSHFZdKLMLaCwQ=="
---

